Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio. The company has also decided to ...

Cough syrup sales shift cautiously towards established brands amid controversy, impacting consumer and doctor preferences, ...

REUTERS - Delhi High Court granted U.S. drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk ...

Corex is a combination of chlopheniramine maleate and codeine syrup -- one of 344 drug combinations India banned over the weekend after a government panel of experts found they had "no therapeutic ...

Pharmaceutical company Pfizer has with immediate effect stopped making and selling cough syrup Corex in India after the government prohibited fixed dose combination of Chlopheniramine Maleate + ...

Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio. The company has also decided to discontinue the ...

Pfizer shares declined over 5 per cent in the morning trade on Monday after the company informed stock exchanges that it has discontinued the manufacture and sale of its drug “Corex” with immediate ...

A farmer had to spend two months in jail for walking along with a friend who was carrying 20 bottles of Corex cough syrup Strange as it may sound a person spent almost two months in prison for trying ...

MUMBAI, March 14 (Reuters) - U.S. pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to ...

Drug maker Pfizer has decided to discontinue the manufacturing of Corex cough syrup. New Delhi: Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ...